Recovery of liver function after the cessation of preoperative chemotherapy for colorectal liver metastasis

Annals of Surgical Oncology

Volumn 17, Issue 10, 2010, Pages 2747-2755

  Takamoto, Takeshi ^a   Hashimoto, Takuya ^a   Sano, Keiji ^a   Maruyama, Yoshikazu ^a   Inoue, Kazuto ^a   Ogata, Satoshi ^a   Takemura, Tamiko ^a   Kokudo, Norihiro ^b   Makuuchi, Masatoshi ^a  

^a JAPANESE RED CROSS MEDICAL CENTER   (Japan)

^b Artificial Organ and Transplantation Division   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; FLUOROURACIL; FOLINIC ACID; INDOCYANINE GREEN; IRINOTECAN; OXALIPLATIN;

ABDOMINAL ABSCESS; ABDOMINAL BLEEDING; ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CATHETER INFECTION; COLORECTAL CANCER; FEMALE; HEPATITIS C; HISTOPATHOLOGY; HUMAN; ILEUS; LIVER FAILURE; LIVER FUNCTION; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; PERCUTANEOUS DRAINAGE; PNEUMONIA; POSTOPERATIVE HEMORRHAGE; REOPERATION; TREATMENT WITHDRAWAL;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; INDOCYANINE GREEN; LEUCOVORIN; LIVER; LIVER FUNCTION TESTS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; ORGANOPLATINUM COMPOUNDS; PREOPERATIVE CARE; PROSPECTIVE STUDIES; RECOVERY OF FUNCTION; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 78049455734     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-1074-4     Document Type: Article

References (45)

1. B Nordlinger M Guiguet JC Vaillant P Balladur K Boudjema P Bachellier, et al. 1996 Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie Cancer 77 1254 1262 1:STN:280: DyaK287pslCiuw%3D%3D 10.1002/(SICI)1097-0142(19960401)77:7<1254::AID- CNCR5>3.0.CO;2-I 8608500
2. M Rees G Plant S Bygrave 1997 Late results justify resection for multiple hepatic metastases from colorectal cancer Br J Surg. 84 1136 1140 1:STN:280:DyaK2svisVGnuw%3D%3D 10.1002/bjs.1800840828 9278662
3. Y Fong J Fortner RL Sun MF Brennan LH Blumgart 1999 Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases Ann Surg. 230 309 318 1:STN:280: DyaK1MvitFahsw%3D%3D 10.1097/00000658-199909000-00004 10493478 discussion 318-21
4. S Giacchetti M Itzhaki G Gruia R Adam R Zidani F Kunstlinger, et al. 1999 Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery Ann Oncol. 10 663 669 1:STN:280:DyaK1MzntVOktA%3D%3D 10.1023/A:1008347829017 10442188
5. MA Choti JV Sitzmann MF Tiburi W Sumetchotimetha R Rangsin RD Schulick, et al. 2002 Trends in long-term survival following liver resection for hepatic colorectal metastases Ann Surg. 235 759 766 10.1097/00000658-200206000-00002 12035031
6. R Adam G Pascal D Azoulay K Tanaka D Castaing H Bismuth 2003 Liver resection for colorectal metastases: the third hepatectomy Ann Surg. 238 871 883 10.1097/01.sla.0000098112.04758.4e 14631224 discussion 83-4
7. G Steele Jr TS Ravikumar 1989 Resection of hepatic metastases from colorectal cancer. Biologic perspective Ann Surg. 210 127 138 10.1097/00000658-198908000-00001 2667471
8. J Scheele 1993 Hepatectomy for liver metastases Br J Surg. 80 274 276 1:STN:280:DyaK3s3jtVekug%3D%3D 10.1002/bjs.1800800302 8472130
9. EK Abdalla JN Vauthey LM Ellis V Ellis R Pollock KR Broglio, et al. 2004 Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases Ann Surg. 239 818 825 10.1097/01.sla.0000128305.90650.71 15166961 discussion 825-7
10. R Adam V Delvart G Pascal A Valeanu D Castaing D Azoulay, et al. 2004 Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival Ann Surg. 240 644 657 10.1097/01.sla.0000145964.08365.01 15383792 discussion 657-8
11. WC Fowler BL Eisenberg JP Hoffman 1992 Hepatic resection following systemic chemotherapy for metastatic colorectal carcinoma J Surg Oncol. 51 122 125 1:STN:280:DyaK3s%2Fit1Omug%3D%3D 10.1002/jso.2930510212 1405651
12. SR Alberts WL Horvath WC Sternfeld RM Goldberg MR Mahoney SR Dakhil, et al. 2005 Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group phase II study J Clin Oncol. 23 9243 9249 1:CAS:528:DC%2BD28Xnt1yntw%3D%3D 10.1200/JCO.2005.07.740 16230673
13. JN Vauthey TM Pawlik D Ribero TT Wu D Zorzi PM Hoff, et al. 2006 Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases J Clin Oncol. 24 2065 2072 1:CAS:528:DC%2BD28Xlt1amurY%3D 10.1200/JCO.2005.05.3074 16648507
14. G Nuzzo F Giuliante F Ardito M Vellone C Pozzo A Cassano, et al. 2007 Liver resection for primarily unresectable colorectal metastases downsized by chemotherapy J Gastrointest Surg. 11 318 324 10.1007/s11605-006-0070-2 17458605
15. AA Parikh B Gentner TT Wu SA Curley LM Ellis JN Vauthey 2003 Perioperative complications in patients undergoing major liver resection with or without neoadjuvant chemotherapy J Gastrointest Surg. 7 1082 1088 10.1016/j.gassur.2003.08.005 14675719
16. FG Fernandez J Ritter JW Goodwin DC Linehan WG Hawkins SM Strasberg 2005 Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases J Am Coll Surg. 200 845 853 10.1016/j.jamcollsurg.2005.01.024 15922194
17. L Rubbia-Brandt V Audard P Sartoretti AD Roth C Brezault M Le Charpentier, et al. 2004 Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer Ann Oncol. 15 460 466 1:STN:280:DC%2BD2c7gvVeksQ%3D%3D 10.1093/annonc/mdh095 14998849
18. M Karoui C Penna M Amin-Hashem E Mitry S Benoist B Franc, et al. 2006 Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases Ann Surg. 243 1 7 10.1097/01.sla.0000193603.26265.c3 16371728
19. T Aloia M Sebagh M Plasse V Karam F Levi S Giacchetti, et al. 2006 Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases J Clin Oncol. 24 4983 4990 1:CAS:528:DC%2BD28Xht1GnurzI 10.1200/JCO.2006.05.8156 17075116
20. B Nordlinger H Sorbye B Glimelius GJ Poston PM Schlag P Rougier, et al. 2008 Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial Lancet. 371 1007 1016 1:CAS:528: DC%2BD1cXjs1Sltbg%3D 10.1016/S0140-6736(08)60455-9 18358928
21. AZ Khan G Morris-Stiff M Makuuchi 2009 Patterns of chemotherapy-induced hepatic injury and their implications for patients undergoing liver resection for colorectal liver metastases J Hepatobiliary Pancreat Surg. 16 137 144 10.1007/s00534-008-0016-z 19093069
22. M Makuuchi T Kosuge T Takayama S Yamazaki T Kakazu S Miyagawa, et al. 1993 Surgery for small liver cancers Semin Surg Oncol. 9 298 304 1:STN:280:DyaK2c%2FitlKltw%3D%3D 10.1002/ssu.2980090404 8210909
23. K Kubota M Makuuchi K Kusaka T Kobayashi K Miki K Hasegawa, et al. 1997 Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors Hepatology. 26 1176 1181 1:STN:280:DyaK1c%2Fis1KrsA%3D%3D 9362359
24. H Imamura Y Seyama N Kokudo A Maema Y Sugawara K Sano, et al. 2003 One thousand fifty-six hepatectomies without mortality in 8 years Arch Surg. 138 1198 1206 10.1001/archsurg.138.11.1198 14609867 discussion 1206
25. A de Gramont A Figer M Seymour M Homerin A Hmissi J Cassidy, et al. 2000 Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer J Clin Oncol. 18 2938 2947 10944126
26. JY Douillard D Cunningham AD Roth M Navarro RD James P Karasek, et al. 2000 Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial Lancet. 355 1041 1047 1:CAS:528:DC%2BD3cXisFOnsb4%3D 10.1016/S0140- 6736(00)02034-1 10744089
27. A de Gramont JF Bosset C Milan P Rougier O Bouche PL Etienne, et al. 1997 Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study J Clin Oncol. 15 808 815 9053508
28. H Imamura Y Seyama N Kokudo T Aoki K Sano M Minagawa, et al. 2004 Single and multiple resections of multiple hepatic metastases of colorectal origin Surgery. 135 508 517 10.1016/j.surg.2003.10.009 15118588
29. S Kawasaki M Makuuchi T Kakazu S Miyagawa T Takayama T Kosuge, et al. 1994 Resection for multiple metastatic liver tumors after portal embolization Surgery. 115 674 677 1:STN:280:DyaK2c3lsFyktg%3D%3D 8197557
30. H Imamura R Shimada M Kubota Y Matsuyama A Nakayama S Miyagawa, et al. 1999 Preoperative portal vein embolization: an audit of 84 patients Hepatology. 29 1099 1105 1:STN:280:DyaK1M7pslSrug%3D%3D 10.1002/hep.510290415 10094953
31. M Makuuchi T Mori P Gunven S Yamazaki H Hasegawa 1987 Safety of hemihepatic vascular occlusion during resection of the liver Surg Gynecol Obstet. 164 155 158 1:STN:280:DyaL2s7itVOntA%3D%3D 3810429
32. D Dindo N Demartines PA Clavien 2004 Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey Ann Surg. 240 205 213 10.1097/01.sla.0000133083.54934.ae 15273542
33. PA Clavien J Barkun ML de Oliveira JN Vauthey D Dindo RD Schulick, et al. 2009 The Clavien-Dindo classification of surgical complications: five-year experience Ann Surg. 250 187 196 10.1097/SLA.0b013e3181b13ca2 19638912
34. KE Behrns GG Tsiotos NF DeSouza MK Krishna J Ludwig DM Nagorney 1998 Hepatic steatosis as a potential risk factor for major hepatic resection J Gastrointest Surg. 2 292 298 1:STN:280:DyaK1M%2FlvF2ksQ%3D%3D 10.1016/S1091-255X(98)80025-5 9841987
35. DA Kooby Y Fong A Suriawinata M Gonen PJ Allen DS Klimstra, et al. 2003 Impact of steatosis on perioperative outcome following hepatic resection J Gastrointest Surg. 7 1034 1044 10.1016/j.gassur.2003.09.012 14675713
36. DE Kleiner EM Brunt M Van Natta C Behling MJ Contos OW Cummings, et al. 2005 Design and validation of a histological scoring system for nonalcoholic fatty liver disease Hepatology. 41 1313 1321 10.1002/hep.20701 15915461
37. H Nakano E Oussoultzoglou E Rosso S Casnedi MP Chenard-Neu P Dufour, et al. 2008 Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy Ann Surg. 247 118 124 10.1097/SLA.0b013e31815774de 18156931
38. L McCormack H Petrowsky W Jochum K Furrer PA Clavien 2007 Hepatic steatosis is a risk factor for postoperative complications after major hepatectomy: a matched case-control study Ann Surg. 245 923 930 10.1097/01.sla.0000251747.80025.b7 17522518
39. ME Rinella E Alonso S Rao P Whitington J Fryer M Abecassis, et al. 2001 Body mass index as a predictor of hepatic steatosis in living liver donors Liver Transpl. 7 409 414 1:STN:280:DC%2BD3MvjsFOktg%3D%3D 10.1053/jlts.2001.23787 11349260
40. D Ribero H Wang M Donadon D Zorzi MB Thomas C Eng, et al. 2007 Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases Cancer. 110 2761 2767 10.1002/cncr.23099 17960603
41. S Hasegawa K Horibe T Kawabe K Kato S Kojima T Matsuyama, et al. 1998 Veno-occlusive disease of the liver after allogeneic bone marrow transplantation in children with hematologic malignancies: incidence, onset time and risk factors Bone Marrow Transplant. 22 1191 1197 1:STN:280:DyaK1M7htVSitg%3D%3D 10.1038/sj.bmt.1701506 9894723
42. A Iguchi R Kobayashi M Yoshida K Kobayashi K Matsuo I Kitajima, et al. 2001 Vascular endothelial growth factor (VEGF) is one of the cytokines causative and predictive of hepatic veno-occlusive disease (VOD) in stem cell transplantation Bone Marrow Transplant. 27 1173 1180 1:STN:280: DC%2BD3MrgtV2nsw%3D%3D 10.1038/sj.bmt.1703061 11551028
43. FK Welsh HS Tilney PP Tekkis TG John M Rees 2007 Safe liver resection following chemotherapy for colorectal metastases is a matter of timing Br J Cancer. 96 1037 1042 1:STN:280:DC%2BD2s3gt12jtA%3D%3D 10.1038/sj.bjc.6603670 17353923
44. C Hubert C Fervaille C Sempoux Y Horsmans Y Humblet JP Machiels, et al. 2010 Prevalence and clinical relevance of pathological hepatic changes occurring after neoadjuvant chemotherapy for colorectal liver metastases Surgery. 147 185 194 10.1016/j.surg.2009.01.004 20109620
45. D Jaeck E Oussoultzoglou E Rosso M Greget JC Weber P Bachellier 2004 A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases Ann Surg. 240 1037 1049 10.1097/01.sla.0000145965. 86383.89 15570209 discussion 1049-51